B6;129P2-Bcl11bem1Srft/H

Status

Available to order

EMMA IDEM:13082
Citation informationRRID:IMSR_EM:13082 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameB6;129P2-Bcl11bem1Srft/H
Alternative nameBCL11B p.R3S
Strain typeEndonuclease-mediated
Allele/Transgene symbolBcl11bem1
Gene/Transgene symbolBcl11b

Information from provider

ProviderStephen Twigg
Provider affiliationThe MRC Weatherall Institute of Molecular Medicine
Genetic informationMouse embryonic stem (ES) cells (E14Tg2aIV, 129P2/OlaHsd) were transfected with pX458 (Addgene 48 138) containing a guide sequence targeting a region near the Bcl11b translation start site (5-CCGCAAACAGGGCAACCCGC-3) and an oligonucleotide donor for homology directed repair and introduction of the c.7C to A mutation (5-gcggcggcggcggctcagaccccctccccggcccgcatctgtg cagctttccgggcgatgccagaatagatgccgGggcaatgtccAg ccgcaaacagggcaacccgcagcacttgtcccagaggga-3). Briefly, ES cells were seeded onto gelatin-coated 6-well plates at 3×10^5 cells per well 1 day before transfection with 3.3 μg plasmid, 10 μl of 10 μM donor complexed with 20 μl Fugene HD (Promega) oligonucleotide in a total volume of 100 μl made up with serum free medium. After 24 h, cells were sorted for green fluorescent protein-positive cells using fluorescence-activated cell sorting in a 96-well format. A homozygous c.7C to A ES clone was identified and was injected into blastocysts (C57BL/6) for chimera generation. Several chimeric mice were produced, and the mutant allele was successfully transmitted through the germline.
Phenotypic informationHomozygous:
Homozygous mouse is not viable (neonatal lethality).

Heterozygous:
Heterozygous, Bcl11bR3S/+mice were born at Mendelian ratios, survived into adulthood without gross anatomical abnormalities and bred normally. However, examination of calvarial sutures by micro-CT revealed that Bcl11bR3S/+ mice exhibited variable and partial, bilateral osteogenic fusion of the coronal suture that was accompanied by narrowing of the sagittal and lambdoid sutures by ca. 50% at P0. Other calvarial and facial sutures in the Bcl11bR3S/+ mice were indistinguishable from those of wild-type mice. Homozygous, mutant mice (Bcl11bR3S/R3S) recapitulated perinatal lethality of Bcl11b−/− mice, due to apparent respiratory insufficiency, as well as multi-suture craniosynostosis at P0 involving the coronal (bilateral), interfrontal, sagittal, interparietal and temporal sutures. However, in marked contrast to Bcl11b−/− mice or those lacking BCL11B in cells derived from neural crest, Bcl11bR3S/R3S mice did not exhibit fusion of facial sutures. The sutural mesenchyme of the facial skeleton is the most sensitive to loss of BCL11B and frequently undergoes premature osteogenic differentiation in Bcl11b+/− heterozygotes
Breeding historyFounder line: M00770521 (chimeric founder line) Original genetic background: E14Tg2aIV, 129P2/OlaHsd Current genetic background: C57BL/6
References
  • A de novo substitution in BCL11B leads to loss of interaction with transcriptional complexes and craniosynostosis.;Goos Jacqueline A C, Vogel Walter K, Mlcochova Hana, Millard Christopher J, Esfandiari Elahe, Selman Wisam H, Calpena Eduardo, Koelling Nils, Carpenter Evan L, Swagemakers Sigrid M A, van der Spek Peter J, Filtz Theresa M, Schwabe John W R, Iwaniec Urszula T, Mathijssen Irene M J, Leid Mark, Twigg Stephen R F, ;2019;Human molecular genetics;28;2501-2513; 31067316
Homozygous fertileno
Homozygous viableno
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreMary Lyon Centre at MRC Harwell, Oxford, United Kingdom
Animals used for archivingheterozygous C57BL/6J males
Breeding at archiving centreGene targeting was performed in E14Tg2aIV (129P2/OlaHsd) ES cells. The ES cells were injected into C57BL/6J-derived blastocysts. All subsequent crosses have been to C57BL/6J mice.

Disease and phenotype information

IMPC phenotypes (gene matching)
  • abnormal eyelid fusion / IMPC
  • abnormal bone structure / IMPC
  • increased vertical activity / IMPC
  • increased bone mineral content / IMPC
  • increased fasting circulating glucose level / IMPC
  • preweaning lethality, complete penetrance / IMPC
  • abnormal facial morphology / IMPC

Literature references

  • A de novo substitution in BCL11B leads to loss of interaction with transcriptional complexes and craniosynostosis.;Goos Jacqueline A C, Vogel Walter K, Mlcochova Hana, Millard Christopher J, Esfandiari Elahe, Selman Wisam H, Calpena Eduardo, Koelling Nils, Carpenter Evan L, Swagemakers Sigrid M A, van der Spek Peter J, Filtz Theresa M, Schwabe John W R, Iwaniec Urszula T, Mathijssen Irene M J, Leid Mark, Twigg Stephen R F, ;2019;Human molecular genetics;28;2501-2513; 31067316

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*
  • Tissue - Types of tissue, service fee and delivery time available upon request

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable), as well as a CRISPR surcharge.

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
MTA will be issued after an order has been submitted.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).